Anzeige
Mehr »
Login
Dienstag, 14.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Uran-Rallye: Preise ziehen wieder an - Jetzt nicht den Einstieg verpassen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
219 Leser
Artikel bewerten:
(1)

The Business Research Company: Interventional Oncology Devices Market Analysis Shows 9% Growth Rate Through 2026

TBRC's interventional oncology devices market report forecasts the market to reach $3Bn by 2026

LONDON, March 23, 2022 /PRNewswire/ -- The global interventional oncology devices market size is expected to grow from $1.97 billion in 2021 to $2.15 billion in 2022 at a compound annual growth rate (CAGR) of 9.4%. TBRC's interventional oncology devices market forecast then sees it growing to $3.03 billion in 2026 at a CAGR of 8.9%.

tbrc_logo

Request a free sample of the Interventional Oncology Devices Market Report

Regional Analysis And Growth Opportunities

North America is the largest region as per interventional oncology devices market analysis, accounting for 35.6% of the total in 2021. It is followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the interventional oncology devices market will be Asia Pacific and South America, where growth will be at CAGRs of 8.1% and 7.2% respectively. These will be followed by North America and Western Europe.

Interventional Oncology Devices Market Trends

Companies are focusing on deploying robotics technology in interventional oncology devices to improve efficiency of oncology procedures. The robotic system integrates image-based planning and navigation with the installation of different instruments to the desired body part with better accuracy and efficiency.

For example, in November 2021, Quantum Surgical, a France-based medical robotics company, introduced Epione, a new category of interventional oncology robotics. This robotic-assisted technology provides physicians with advanced tools to plan, target, deliver and confirm tumor ablation. In October 2019, the first robotic system of XACT Robotics Ltd, an Israel-based company, was approved by the United States Food and Drug Administration for use during computed tomography (CT) guided percutaneous interventional procedures.

Competitive Landscape

The interventional oncology devices market is highly concentrated with a small number of large players dominating the market. The top ten competitors in the market made up to 95% of the total market in 2020. Boston Scientific Corporation was the largest competitor with 23.27% of the market, followed by Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Merit Medical Systems, Inc., Medtronic plc, Cook Medical LLC, HealthTronics, Varian Medical Systems Inc., and AngioDynamics Inc.

See more on the Interventional Oncology Devices Market Report

Check out similar market reports:

Interventional Radiology Global Market Report 2022 - By Product (MRI, Ultrasound Imaging, CT Scanners, Angiography Systems, Fluoroscopy Systems, Biopsy Devices), By Procedure (Angioplasty, Angiography, Biopsy And Drainage, Embolization, Thrombolysis, Vertebroplasty, Nephrostomy), By Application (Oncology, Cardiology, Urology And Nephrology, Gastroenterology) - Market Size, Trends, And Global Forecast 2022-2026

Oncology Devices Global Market Report 2022 - By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radiation Therapy), By End User (Hospitals, Cancer Research Institutes) - Market Size, Trends, And Global Forecast 2022-2026

Oncology Drugs Global Market Report 2022 - By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) - Market Size, Trends, And Global Forecast 2022-2026

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Information

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Logo: https://mma.prnewswire.com/media/1751581/tbrc_logo.jpg

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2022 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.